Lower Plasma Levels of Selective VGF (Non-Acronymic) Peptides in Bipolar Disorder: Comparative Analysis Reveals Distinct Patterns Across Mood Disorders and Healthy Controls

Overview

Journal Neuropsychobiology

Specialty Neurology

Date 2024 Sep 8

PMID 39245034

Authors

Cristina Cocco

Barbara Noli

Barbara Manconi

Cristina Contini

Elias Manca

Claudia Pisanu

Anna Meloni

Mirko Manchia

Pasquale Paribello

Caterina Chillotti

Raffaella Ardau

Giovanni Severino

Alessio Squassina

Affiliations

Soon will be listed here.

Abstract

Introduction: Discriminating bipolar disorder (BD) from major depressive disorder (MDD) remains a challenging clinical task. Identifying specific peripheral biosignatures that can differentiate between BD and MDD would significantly increase diagnostic accuracy. Dysregulated neuroplasticity is implicated in BD and MDD, and psychotropic medications restore specific disrupted processes by increasing neurotrophic signalling. The nerve growth factor inducible vgf gene (non-acronymic) encodes a precursor protein named proVGF, which undergoes proteolytic processing to produce several VGF peptides, some of which were suggested to be implicated in mood disorders and have antidepressant effects. Since the presence of VGF peptides in humans has been exclusively investigated in brain and cerebrospinal fluid, we aimed to identify which VGF peptides are present in the plasma and to investigate whether their levels could differentiate BD from MDD as well as responders from non-responders to pharmacological interventions.

Methods: VGF peptides were investigated in plasma from patients diagnosed with MDD (n = 37) or BD (n = 40 under lithium plus n = 29 never exposed to lithium), as well as healthy controls (HC; n = 36).

Results: Three VGF peptides (TLQP-11, AQEE-14, and NAPP-19) were identified using spectrometry analysis of plasma from HC. These peptides were then measured in the entire sample using ELISA, which showed significantly lower levels of AQEE and NAPP in BD than in HC and MDD (p = 5.0 × 10-5, p = 0.001, respectively).

Conclusion: Our findings suggest that lower plasma levels of NAPP and AQEE are specifically associated with BD, thus possibly representing a diagnostic biomarker in mood disorders.

References

Manca E, Noli B, Corda G, El-Hassani M, Manai A, Sanna F . VGF modifications related to nigrostriatal dopaminergic neurodegeneration induced by the pesticide fipronil in adult male rats. Ann Anat. 2023; 252:152194. DOI: 10.1016/j.aanat.2023.152194. View

Thakker-Varia S, Krol J, Nettleton J, Bilimoria P, Bangasser D, Shors T . The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus. J Neurosci. 2007; 27(45):12156-67. PMC: 3363962. DOI: 10.1523/JNEUROSCI.1898-07.2007. View

Alder J, Thakker-Varia S, Bangasser D, Kuroiwa M, Plummer M, Shors T . Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity. J Neurosci. 2003; 23(34):10800-8. PMC: 3374594. View

Li X, Ge H, Zhou D, Wu X, Qi G, Chen Z . Reduced serum VGF levels are linked with suicide risk in Chinese Han patients with major depressive disorder. BMC Psychiatry. 2020; 20(1):225. PMC: 7216356. DOI: 10.1186/s12888-020-02634-9. View

Noli B, Brancia C, Corda G, Ferri G, Cocco C . Dynamic of TLQP-peptides upon fasting. Tissue Cell. 2020; 65:101368. DOI: 10.1016/j.tice.2020.101368. View

Puglisi-Allegra S, Ruggieri S, Fornai F . Translational evidence for lithium-induced brain plasticity and neuroprotection in the treatment of neuropsychiatric disorders. Transl Psychiatry. 2021; 11(1):366. PMC: 8257731. DOI: 10.1038/s41398-021-01492-7. View

Manchia M, Adli M, Akula N, Ardau R, Aubry J, Backlund L . Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report. PLoS One. 2013; 8(6):e65636. PMC: 3686769. DOI: 10.1371/journal.pone.0065636. View

Cattaneo A, Bocchio-Chiavetto L, Zanardini R, Milanesi E, Placentino A, Gennarelli M . Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. Int J Neuropsychopharmacol. 2009; 13(1):103-8. DOI: 10.1017/S1461145709990812. View

Molteni L, Rizzi L, Bresciani E, Possenti R, Passeri P, Ghe C . Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells. Front Pharmacol. 2017; 8:167. PMC: 5371653. DOI: 10.3389/fphar.2017.00167. View

10.

Squassina A, Manchia M, Pisanu C, Ardau R, Arzedi C, Bocchetta A . Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications. Neuropsychopharmacology. 2020; 45(13):2229-2238. PMC: 7784910. DOI: 10.1038/s41386-020-00844-z. View

11.

DAmato F, Noli B, Angioni L, Cossu E, Incani M, Messana I . VGF Peptide Profiles in Type 2 Diabetic Patients' Plasma and in Obese Mice. PLoS One. 2015; 10(11):e0142333. PMC: 4643017. DOI: 10.1371/journal.pone.0142333. View

12.

Singh T, Rajput M . Misdiagnosis of bipolar disorder. Psychiatry (Edgmont). 2010; 3(10):57-63. PMC: 2945875. View

13.

Brancia C, Noli B, Boido M, Boi A, Puddu R, Borghero G . VGF Protein and Its C-Terminal Derived Peptides in Amyotrophic Lateral Sclerosis: Human and Animal Model Studies. PLoS One. 2016; 11(10):e0164689. PMC: 5063282. DOI: 10.1371/journal.pone.0164689. View

14.

Thakker-Varia S, Jean Y, Parikh P, Sizer C, Jernstedt Ayer J, Parikh A . The neuropeptide VGF is reduced in human bipolar postmortem brain and contributes to some of the behavioral and molecular effects of lithium. J Neurosci. 2010; 30(28):9368-80. PMC: 6632435. DOI: 10.1523/JNEUROSCI.5987-09.2010. View

15.

Sathe G, Na C, Renuse S, Madugundu A, Albert M, Moghekar A . Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease. Proteomics Clin Appl. 2018; 13(4):e1800105. PMC: 6639119. DOI: 10.1002/prca.201800105. View

16.

Hultman R, Mague S, Li Q, Katz B, Michel N, Lin L . Dysregulation of Prefrontal Cortex-Mediated Slow-Evolving Limbic Dynamics Drives Stress-Induced Emotional Pathology. Neuron. 2016; 91(2):439-52. PMC: 4986697. DOI: 10.1016/j.neuron.2016.05.038. View

17.

Kessler R, Chiu W, Demler O, Merikangas K, Walters E . Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62(6):617-27. PMC: 2847357. DOI: 10.1001/archpsyc.62.6.617. View

18.

Lin W, Jiang C, Sadahiro M, Bozdagi O, Vulchanova L, Alberini C . VGF and Its C-Terminal Peptide TLQP-62 Regulate Memory Formation in Hippocampus via a BDNF-TrkB-Dependent Mechanism. J Neurosci. 2015; 35(28):10343-56. PMC: 4502270. DOI: 10.1523/JNEUROSCI.0584-15.2015. View

19.

Jiang H, Chen S, Lu N, Yue Y, Yin Y, Zhang Y . Reduced serum VGF levels were reversed by antidepressant treatment in depressed patients. World J Biol Psychiatry. 2017; 18(8):586-591. DOI: 10.1080/15622975.2016.1224923. View

20.

Cocco C, Manai A, Manca E, Noli B . Brain-Biomarker Changes in Body Fluids of Patients with Parkinson's Disease. Int J Mol Sci. 2023; 24(13). PMC: 10341952. DOI: 10.3390/ijms241310932. View